These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 8039842

  • 21. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
    Intengan HD, Park JB, Schiffrin EL.
    Hypertension; 1999 Oct; 34(4 Pt 2):907-13. PubMed ID: 10523383
    [Abstract] [Full Text] [Related]

  • 22. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M, Gopalakrishnan V, McNeill JR.
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [Abstract] [Full Text] [Related]

  • 23. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M, Gopalakrishnan V, Wilson TW, McNeill JR.
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats.
    Li JS, Schiffrin EL.
    J Hypertens; 1995 Jun; 13(6):647-52. PubMed ID: 7594422
    [Abstract] [Full Text] [Related]

  • 26. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.
    Li JS, Knafo L, Turgeon A, Garcia R, Schiffrin EL.
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H88-93. PubMed ID: 8760162
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS, Sventek P, Schiffrin EL.
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [Abstract] [Full Text] [Related]

  • 29. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.
    Viel EC, Benkirane K, Javeshghani D, Touyz RM, Schiffrin EL.
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H281-8. PubMed ID: 18487445
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.
    Yu M, Gopalakrishnan V, McNeill JR.
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):845-8. PubMed ID: 10480481
    [Abstract] [Full Text] [Related]

  • 32. Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses.
    Tostes Passaglia RC, David FL, Fortes ZB, Nigro D, Scivoletto R, Catelli De Carvalho MH.
    Br J Pharmacol; 2000 Jul; 130(5):1092-8. PubMed ID: 10882394
    [Abstract] [Full Text] [Related]

  • 33. Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats.
    Nguyen PV, Parent A, Deng LY, Flückiger JP, Thibault G, Schiffrin EL.
    Hypertension; 1992 Feb; 19(2 Suppl):II98-104. PubMed ID: 1310486
    [Abstract] [Full Text] [Related]

  • 34. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 35. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
    Day R, Larivière R, Schiffrin EL.
    Am J Hypertens; 1995 Mar; 8(3):294-300. PubMed ID: 7794580
    [Abstract] [Full Text] [Related]

  • 36. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat.
    Larivière R, Deng LY, Day R, Sventek P, Thibault G, Schiffrin EL.
    J Mol Cell Cardiol; 1995 Oct; 27(10):2123-31. PubMed ID: 8576929
    [Abstract] [Full Text] [Related]

  • 37. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
    Molero MM, Giulumian AD, Reddy VB, Ludwig LM, Pollock JS, Pollock DM, Rusch NJ, Fuchs LC.
    J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
    [Abstract] [Full Text] [Related]

  • 38. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
    Larouche I, Schiffrin EL.
    Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
    [Abstract] [Full Text] [Related]

  • 39. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
    Park JB, Schiffrin EL.
    Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393
    [Abstract] [Full Text] [Related]

  • 40. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Johnson RJ, Galligan JJ, Fink GD.
    J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.